IQVIA (IQV) Surges 3.0%: Is This an Indication of Further Gains?

IQVIA Holdings (IQV) shares rallied 3% in the last trading session to close at $197.27. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3.1% loss over the past four weeks.The stock has recorded the price rise as the company’s short-cycle businesses continue to improve on the back of its clients’ launching drugs and executing critical commercial programs.This clinical testing company is expected to post quarterly earnings of $3.11 per share in its upcoming report, which represents a year-over-year change of +9.5%. Revenues are expected to be $3.92 billion, up 1.4% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For IQVIA, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on IQV going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>IQVIA is part of the Zacks Medical - Instruments industry. Thermo Fisher Scientific (TMO), another stock in the same industry, closed the last trading session 1.4% higher at $524.05. TMO has returned 0.1% in the past month.For Thermo Fisher, the consensus EPS estimate for the upcoming report has changed +0.1% over the past month to $5.92. This represents a change of +4.4% from what the company reported a year ago. Thermo Fisher currently has a Zacks Rank of #3 (Hold).Zacks Naming Top 10 Stocks for 2025Want to be tipped off early to our 10 top picks for the entirety of 2025?History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2025. Don’t miss your chance to get in on these stocks when they’re released on January 2.Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report IQVIA Holdings Inc. (IQV): Free Stock Analysis Report Thermo Fisher Scientific Inc. (TMO): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks